Sometimes I read a research study and it seems like I’ve stumbled across a miracle cure. The bacterium Limosilactobacillus reuteri (L. reuteri) had that effect—at least at first glance.
Reality is often a bit more nuanced. L. reuteri can work wonders for certain ailments. And, like other probiotics, dosing is important, even though nobody’s entirely sure what the ideal dose is yet.
That’s why it’s important to get the whole story, and in health and medicine, it’s almost always an evolving tale. Unfortunately, we find ourselves at a cliffhanger with the L. reuteri story. This once-thriving and essential bacteria is now facing extinction due in no small part to antibiotics. In literature, the opposite of a tragedy is a comedy. If humanity can revive L. reuteri, the last laugh might be among the scores of people who no longer need drugs to manage their gut-wrenching gastrointestinal conditions.
If you love this newsletter, please share it with your friends, and let them know they can sign up and browse all of our newsletters here.
Your Feedback
We’d love to hear from you. If you have any suggestions for us to improve, or a wellness story that you’d like us to cover, you can email me at healthnewsletter@epochtimes.nyc
We may feature an excerpt of your response in the next newsletter.
You are receiving this email because you subscribed to The Epoch Times.
The information in this newsletter is not intended to replace a one-on-one relationship with a qualified health care professional and is not intended as medical advice. It is intended as a sharing of knowledge and information from the research and experience of many experts and journalists. The Epoch Times encourages you to make your own health care decisions based upon your research and in partnership with a qualified health care professional.